Organ distribution and pharmacokinetics of titanium after treatment with titanocene dichloride
- 31 October 1988
- journal article
- Published by Elsevier in Toxicology
- Vol. 51 (2-3) , 291-298
- https://doi.org/10.1016/0300-483x(88)90157-6
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Non-platinum group metal antitumor agents. History, current status, and perspectivesChemical Reviews, 1987
- Cytostatische Nicht-Platinmetall-Komplexe: neue Perspektiven für die Krebsbehandlung?The Science of Nature, 1987
- Tumor inhibition by titanocene complexes: Influence upon two xenografted human lung carcinomasZeitschrift für Krebsforschung und Klinische Onkologie, 1987
- Pattern of toxicity by titanocene dichloride in miceZeitschrift für Krebsforschung und Klinische Onkologie, 1986
- Organ toxicity of metallocene dichlorides. The effect of (C5H5)2TiCl2 and (C5H5)2VCl2 on renal structureToxicology, 1986
- Biodistribution and pharmacokinetics of vanadium following intraperitoneal administration of vanadocene dichloride to miceChemico-Biological Interactions, 1985
- The nephrotoxicity of cisplatinLife Sciences, 1983
- Tumor inhibition by metallocenes: Activity against leukemias and detection of the systemic effectPublished by Elsevier ,1981
- Abnormal trace metals in man: TitaniumJournal of Chronic Diseases, 1963
- Bis-cyclopentadienyl Compounds of Ti, Zr, V, Nb and TaJournal of the American Chemical Society, 1954